KR100204096B1 - Preparation method for bis-triazole derivatives - Google Patents

Preparation method for bis-triazole derivatives Download PDF

Info

Publication number
KR100204096B1
KR100204096B1 KR1019970023862A KR19970023862A KR100204096B1 KR 100204096 B1 KR100204096 B1 KR 100204096B1 KR 1019970023862 A KR1019970023862 A KR 1019970023862A KR 19970023862 A KR19970023862 A KR 19970023862A KR 100204096 B1 KR100204096 B1 KR 100204096B1
Authority
KR
South Korea
Prior art keywords
bis
compound
water
triazole
difluorophenyl
Prior art date
Application number
KR1019970023862A
Other languages
Korean (ko)
Other versions
KR19990000773A (en
Inventor
김상린
김지한
박윤영
김형근
이준광
송재경
강동민
Original Assignee
조생현
보령제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조생현, 보령제약주식회사 filed Critical 조생현
Priority to KR1019970023862A priority Critical patent/KR100204096B1/en
Publication of KR19990000773A publication Critical patent/KR19990000773A/en
Application granted granted Critical
Publication of KR100204096B1 publication Critical patent/KR100204096B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/36Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

본 발명은 옥시란 화합물과 실릴 트리아졸을 촉매량의 테트라알킬암모늄할라이드 또는 금속할라이드를 사용하여 2-(2, 4-디플루오로페닐) -1,3-비스(1, 2, 4-트리아졸-1-일)-2-(트리메틸실릴옥시)프로판을 제조하고 산조건하에서 탈실릴화시켜 쉽게 플루코나졸을 높은 수율로 제조하는 방법이다.The present invention utilizes an oxirane compound and silyl triazole in the form of 2- (2,4-difluorophenyl) -1,3-bis (1,2,4-triazole) using catalytic amounts of tetraalkylammonium halides or metal halides. 1-yl) -2- (trimethylsilyloxy) propane is prepared and desilylated under acidic conditions to easily produce fluconazole in high yield.

Description

비스-트리아졸 유도체의 제조방법Method for preparing bis-triazole derivative

본 발명은 항진균작용을 가진 하기 화학식 1의 비스-트리아졸 유도체의 신규 제조방법에 관한 것이다.The present invention relates to a novel method for preparing a bis-triazole derivative of formula (1) having an antifungal action.

Figure kpo00001
Figure kpo00001

화학식 1의 화학물은 일반명 플루코나졸로 잘 알려져 있으며, 그 제조방법으로서 영국 특허 제 2,099,818 호에 의하면 하기 반응식 1처럼 1-[2-(2,4-디플루오로페닐)-2, 3-에폭시프로필] -1h-1, 2, 4- 트리아졸(2) [이하 옥시란화합물 (2) 이라 칭함] 과 1h-1, 2, 4-트리아졸의 반응에 의해 비스-트리아졸 유도체 (1)를 제조하는 방법이 기술되어 있다. 그러나 화학식(2)의 화합물은 1, 2, 4-트리아졸과의 반응성이 낮아 비스트리아졸 유도체 (1)를 얻는 수율이 45%에 불과한 것이 문제점으로 지적되고 있다.The chemical of formula (1) is well known under the common name fluconazole, and according to British Patent No. 2,099,818, the process for preparing 1- [2- (2,4-difluorophenyl) -2,3-epoxy as shown in Scheme 1 below. Propyl] -1h-1, 2, 4-triazole (2) [hereinafter referred to as oxirane compound (2)] and bis-triazole derivative (1) by reaction of 1h-1, 2, 4-triazole (1) A method of making is described. However, it is pointed out that the compound of the formula (2) has a low reactivity with 1, 2, 4-triazole, so that the yield of obtaining the bistriazole derivative (1) is only 45%.

Figure kpo00002
Figure kpo00002

그리고 이스라엘 특허출원 제 105,200 호에는 하기 반응식 2에서와 같이 옥시란화합물(2)과 4-아미노- 1;2, 4- 트리아졸의 반응에 의해 얻을 수 있다고 기술되어 있으나, 이 방법은 산조건하에서 반응이 수행되고 보호기 제거반응이 필요한 점 등의 단점이 지적되고 있다.And in Israel Patent Application No. 105,200, it can be obtained by the reaction of the oxirane compound (2) and 4-amino-1; 2, 4-triazole as shown in Scheme 2 below, but this method under acid conditions It is pointed out that the reaction is carried out and the protection group removal reaction is required.

Figure kpo00003
Figure kpo00003

위에서 설명한 영국 특허 제 2,099,818 호에서는 당량이상의 탄산칼륨조건하에서 반응을 시키고 이스라엘 특허출원 제 105,200 호에서는 당량이상의 아질산나트륨하에서 반응이 진행되는 반면 본 발명은 이러한 단점을 해결한 개선된 제조방법으로 보다 온화한 조건하에서 반응을 하며 높은 수율로 플루코나졸을 수득하는 방법을 제공함을 목적으로 한다.In British Patent No. 2,099,818 described above, the reaction proceeds under equivalents of potassium carbonate, while in Israel Patent Application 105,200, the reaction proceeds under equivalents of sodium nitrite. It is an object to provide a process for obtaining fluconazole in a high yield with the reaction under.

본 발명은 옥시란 화합물 (2)과 실릴 트리아졸을 촉매량의 테트라알킬암모늄할라이드 또는 금속할라이드를 사용하여 2- (2, 4- 디플루오로페닐) - 1, 3 - 비스(1, 2, 4 -트리아졸 - 1 - 일) - 2 - (트리메틸실릴옥시) 프로판 (4)을 제조하고 산조건하에서 탈실릴화시켜 쉽게 플루코나졸(1)을 높은 수율로 제조하는 방법이다.The present invention uses the oxirane compound (2) and silyl triazole in the form of 2- (2,4-difluorophenyl) -1,3-bis (1,2,4) using catalytic amounts of tetraalkylammonium halides or metal halides. (Trimethylsilyloxy) propane (4) is prepared and desilylated under acidic conditions to easily produce fluconazole (1) in high yield.

Figure kpo00004
Figure kpo00004

상기 반응식 3에서 (가) 공정은 2 - (2, 4 - 디플루오로페닐) - 1, 3 - 비스(1, 2, 4 - 트리아졸 -1 - 일)- 2 - (트리메틸실릴옥시) 프로판 (4)을 제조하는 공정으로 공지 방법들은 산이나 염기조건 하에서 반응을 시킨 반면 본 공정은 촉매량의 테트라알킬암모늄플루오라이드를 사용한 보다 온화한 반응조건이며 촉매로 사용한 테트라알킬암모늄플루오라이드와 실릴트리아졸이 옥시란의 반응성을 증가시켜 높은 수율로 2- (2, 4 - 디플루오로페닐) - 1, 3- 비스(1, 2, 4 -트리아졸 - 1 - 일) - 2 - (트리메틸실릴옥시) 프로판 (4)이 제조딤을 알 수 있다. 이때 사용되는 테트라알킬암모늄할라이드로는 테트라부틸암모늄플루오라이드, 테트라부틸암모늄브로마이드, 테트라부틸암모늄요오다이드 등이며 금속할라이드로는 나트륨플루오라이드, 칼륨플루오라이드, 나트륨요오다이드 등이 있으며 0.001∼0.05 당량 사용된다.In the scheme 3, the (a) process is 2- (2,4-difluorophenyl) -1,3-bis (1,2,4-triazol-1-yl) -2- (trimethylsilyloxy) propane (4) Processes known in the art are those which are reacted under acidic or basic conditions, while this process is a milder reaction condition using a catalytic amount of tetraalkylammonium fluoride. The catalysts are tetraalkylammonium fluoride and silyltriazole. Increasing the reactivity of the oxirane to yield high yields of 2- (2,4-difluorophenyl) -1,3-bis (1,2,4-triazol-1-yl) -2- (trimethylsilyloxy) It can be seen that propane 4 is produced. The tetraalkylammonium halides used here include tetrabutylammonium fluoride, tetrabutylammonium bromide, tetrabutylammonium iodide, and the metal halides include sodium fluoride, potassium fluoride and sodium iodide. Equivalents are used.

실릴트리아졸은 옥시란 화합물(2)의 1.1 ∼ 1.3당량을 사용하고 반응온도는 60∼100℃가 바람직하다. 이 때 사용한 용매로는 디메틸포름아미드, 디메틸설폭사이드, 테트라하이드로퓨란 등을 들 수 있다.The silyltriazole uses 1.1 to 1.3 equivalents of the oxirane compound (2), and the reaction temperature is preferably 60 to 100 ° C. Examples of the solvent used at this time include dimethylformamide, dimethyl sulfoxide, tetrahydrofuran and the like.

이렇게 얻어진 화합물 (4)은 핵자기공명, 적외선 스펙트럼, 질량분석, 원소분석 등 여러 가지 분석 방법에 의해 확인되었다.Compound (4) thus obtained was confirmed by various analytical methods such as nuclear magnetic resonance, infrared spectrum, mass spectrometry and elemental analysis.

(나)공정은 실온에서 2- (2, 4 - 디플루오로페닐) - 1, 3 - 비스(1, 2, 4 - 트리아졸 - 1 - 일) -2 -(트리메틸실릴옥시)프로판 (4)을 산조건하에서 탈실릴화시켜 플루코나졸(1)을 쉽게 제조한다. 이 때 사용되는 용매는 디메틸포름아미드, 디메틸설폭사이드, 테트라하이로퓨란, 메틸렌클로라이드, 물 등이며 필요하면 혼합용매를 사용하다.(B) Process is 2- (2,4-difluorophenyl) -1,3-bis (1,2,4-triazol-1-yl) -2- (trimethylsilyloxy) propane (4 Fluconazole (1) is readily prepared by desilylating under acidic conditions. At this time, the solvent used is dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, methylene chloride, water and the like, and a mixed solvent is used if necessary.

또한 반응용매로 사용되는 N, N-디메칠포름아미드, 디메칠설폭사이드는 비등점이 높은 용매이기 때문에 제거하기 위해서는 증류수를 사용하는 것이 가장 좋은 방법이다. 그러나 영국 특허 제 2.099,818 호에서는 N, N-디메칠포름아미드를 제거하기 위해 증류수를 사용할 경우 목적화합물 (1)이 물층에 용해되어 녹아나가기 때문에 수율을 감소시킨다. 본 발명에서는 2-(2, 4-디플루오로페닐) -1, 3-비스(1, 2, 4-트리아졸 -1-일)-2-(트리메칠실릴옥시)프로판 (4)제조과정에서 물로 세척하여 N, N-디메칠포름아미드, 디메칠설폭사이드를 제거하여도 화합물(4)의 물에 대한 용해도가 매우 낮기 때문에 수율의 감소없이 용매를 제거할 수 있는 장점이 있다.In addition, since N, N-dimethylformamide and dimethyl sulfoxide used as reaction solvents are high boiling point solvents, distilled water is best used to remove them. However, in British Patent No. 2.099,818, when distilled water is used to remove N, N-dimethylformamide, the target compound (1) is dissolved in and dissolved in the water layer, thereby reducing the yield. In the present invention, 2- (2,4-difluorophenyl) -1,3-bis (1,2,4-triazol-1-yl) -2- (trimethylsilyloxy) propane (4) Even when washed with water to remove N, N- dimethylformamide, dimethyl sulfoxide, the solubility of the compound (4) in water is very low, there is an advantage that the solvent can be removed without reducing the yield.

본 발명의 비스트리아졸 유도체의 제조방법은 종래에 비해 보다 온화한 조건하에서 반응을 할 수 있으며, 보다 높은 수율로 플루코나졸을 수득하는 방법을 제공하게 된다.The method for producing a bistriazole derivative of the present invention can react under milder conditions than before, and provides a method for obtaining fluconazole with a higher yield.

다음 실시예들은 본 발명을 좀더 구체적으로 설명하고자 하는 것이며 본 발명의 범위를 제한하고자 하는 것은 아니다.The following examples are intended to illustrate the invention in more detail and are not intended to limit the scope of the invention.

실시예 1 : 2-(2, 4-디플루오로페닐)-1, 3-비스(1, 2, 4-트리아졸-1-일)-2-(트리메틸실릴옥시)프로판(4)Example 1: 2- (2, 4-difluorophenyl) -1, 3-bis (1, 2, 4-triazol-1-yl) -2- (trimethylsilyloxy) propane (4)

1-[2-(2, 4-디플루오로페닐)-2, 3-에폭시프로필]-1H-1, 2, 4-트리아졸(5.93, 25mmol)를 디메틸포름아미드 10ml 에 녹이고 90℃로 가열한 후 테트라부틸암모늄플루오라이드 0.25ml(1N, THF)을 적가하고 디메틸포름아미드 5ml에 녹인 실릴트리아졸(4.59g, 1.3 당량)을 30분간 서서히 적가하고 90℃에서 2.5시간동안 교반시킨다. 반응물을 실온으로 냉각시킨 후 메틸렌클로라이드 40ml 와 증류수 30ml를 가한다. 유기층을 물 30ml씩 2회 세척하여 디며틸포름아미드를 제거하고 감압하에서 농축한 후 물 40ml를 가하여 교반하면 침전물이 형성되고 여과하면 목적하는 화합물(8.36g, 88.5%)이 수득된다.Dissolve 1- [2- (2,4-difluorophenyl) -2,3-epoxypropyl] -1H-1,2,4-triazole (5.93, 25 mmol) in 10 ml of dimethylformamide and heat to 90 ° C. Then, 0.25 ml (1 N, THF) of tetrabutylammonium fluoride was added dropwise, and silyltriazole (4.59 g, 1.3 equivalents) dissolved in 5 ml of dimethylformamide was slowly added dropwise for 30 minutes, and stirred at 90 ° C. for 2.5 hours. After the reaction was cooled to room temperature, 40 ml of methylene chloride and 30 ml of distilled water were added thereto. The organic layer was washed twice with 30 ml of water to remove digotylformamide, concentrated under reduced pressure, and then stirred with 40 ml of water to form a precipitate. Filtration gave the desired compound (8.36 g, 88.5%).

용점 : 69∼71℃Melting Point: 69 ~ 71 ℃

1H NMR (CDC13) : δ0.13(s. 9H) 4.74(s .4H) 6.75∼6.90(m,1H) 7.25∼7.40(m, 1H) 7.89(s, 2H) 8.07(s, 2H) 1 H NMR (CDC1 3 ): δ 0.13 (s. 9H) 4.74 (s .4H) 6.75 to 6.70 (m, 1H) 7.25 to 7.40 (m, 1H) 7.89 (s, 2H) 8.07 (s, 2H)

실시예 2 : 2-(2, 4-디플루오로페닐)-1, 3-비스(1, 2, 4-트리아졸-1-일)-2-(트리메틸실릴옥시)프로판(4)(8.36g)을 농염산 3.3ml 와 물 30ml를 가하고 실온에서 1시간동안 교반한다. 이 반응들에 4N-가성소오다 수용액으로 서서히 중화(pH 5∼6)하고 메틸렌클로라이드 40ml로 2회 추출하고 무수마그네슘설페이트로 건조하고 감압하에서 농축하면 잔사물이 얻어진다. 이 잔사물에 에틸아세테이트 15ml를 가하여 20분간 환류시키고 실온으로 서서히 냉가하면 조(粗)생성물(6.03g)이 수득된다. 이 조 (粗)생성물 (6.03g)을 농염산 3.3ml와 물 30ml를 가하고 실온에서 교반시킨 후 에틸아세테이트 10ml로 세척하고 다시 4N-가성소오다 수용액으로 서서히 적가 (pH 5∼6)하면 침전물이 생성되고 여과하여 건조하면 표제화합물(5.16g, 76.3%)이 수득된다.Example 2: 2- (2, 4-difluorophenyl) -1, 3-bis (1, 2, 4-triazol-1-yl) -2- (trimethylsilyloxy) propane (4) (8.36 g) was added 3.3 ml of concentrated hydrochloric acid and 30 ml of water and stirred at room temperature for 1 hour. The reactions were gradually neutralized (pH 5-6) with 4N aqueous sodium hydroxide solution, extracted twice with 40 ml of methylene chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to obtain a residue. 15 ml of ethyl acetate was added to the residue, and the mixture was refluxed for 20 minutes and cooled slowly to room temperature to obtain a crude product (6.03 g). This crude product (6.03 g) was added 3.3 ml of concentrated hydrochloric acid and 30 ml of water, stirred at room temperature, washed with 10 ml of ethyl acetate, and slowly added dropwise (pH 5-6) with 4N aqueous sodium hydroxide solution to obtain a precipitate. Formed, filtered and dried to afford the title compound (5.16 g, 76.3%).

용점 : 137∼139℃Melting point: 137 ~ 139 ℃

1R(KBr) : 3100, 1620cm-1 1R (KBr): 3100, 1620cm -1

1H NMR(CDC13) : δ4.40∼4.80(dd, 4H) 5.50(s, 1H) 6.70∼6.90(m, 2H) 7.35∼7.50(m, 1H) 7.85(s, 2H) 8.05(s, 2H) 1 H NMR (CDC1 3 ): δ 4.40 to 4.80 (dd, 4H) 5.50 (s, 1H) 6.70 to 6.50 (m, 2H) 7.35 to 7.50 (m, 1H) 7.85 (s, 2H) 8.05 (s, 2H)

실시예 3 : 2-(2, 4-디플루오로페닐)-1, 3-비스(1H 1, 2, 4-트리아졸-1-일)-2-프로판을(1)Example 3: 2- (2, 4-difluorophenyl) -1, 3-bis (1H 1, 2, 4-triazol-1-yl) -2-propane (1)

1-[2-(2, 4-디플루오로페닐)-2, 3-에폭시프로필]-1H-1, 2, 4-트리아졸(5.93g, 25mmol)를 디메틸포름아미드 10ml 에 녹이고 90℃로 가열한 후 테트라부틸암모늄플루오라이드 0.25ml(1N, THF)을 적가하고 디메틸포름아미드 5ml 에 녹인 실릴트리아졸(4.59g, 1.3당량)을 30분간 서서히 적가하고 90℃에서 3시간동안 교반시킨다. 반응물을 실온으로 냉각시킨 후 메틸렌클로라이드 40ml와 물 30ml를 가한다. 유기층을 물 30ml씩 2회 세척하여 디메틸포름아미드를 제거하고 감압하에서 농축하면 조(眺) 생성물이 수득된다. 물 30ml에 농염산 4.4ml를 가하고 위에서 수득된 조(粗) 생성물을 가하고 실온에서 1시간동안 교반시킨다. 이 반응물을 4N- 가성소오다 수용액으로 서서히 중화기키고 메틸렌클로라이드 50ml로 2회 추출하고 물 20ml로 세척한 후 무수 마그네슘설페이트로 건조시켜 감압하에서 용매를 제거하면 잔사물이 얻어진다. 이 잔사물에 에틸아세테이트 15ml를 가하고 20분 동안 환류시키고 실온으로 서서히 냉각시키면 불순한 목적화합물(6.0g)이 얻어지고 정제를 위해 물 30ml에 농염산 3.3ml를 가하고 생성물을 완전히 녹인 후 4N-가성소오다 수용액으로 서서히 중화하면서 교반하면 침전물이 얻어지고 (pH 5∼6)여과하여 건조하면 표제화합물(5,33g, 69.6%)이 수득된다.Dissolve 1- [2- (2,4-difluorophenyl) -2,3-epoxypropyl] -1H-1,2,4-triazole (5.93 g, 25 mmol) in 10 ml of dimethylformamide and proceed to 90 ° C. After heating, 0.25 ml (1N, THF) of tetrabutylammonium fluoride was added dropwise, and silyltriazole (4.59 g, 1.3 equivalents) dissolved in 5 ml of dimethylformamide was slowly added dropwise for 30 minutes, followed by stirring at 90 ° C for 3 hours. After the reaction was cooled to room temperature, 40 ml of methylene chloride and 30 ml of water were added thereto. The organic layer was washed twice with 30 ml of water to remove dimethylformamide and concentrated under reduced pressure to give crude product. 4.4 ml of concentrated hydrochloric acid are added to 30 ml of water, and the crude product obtained above is added and stirred at room temperature for 1 hour. The reaction was gradually neutralized with 4N aqueous sodium hydroxide solution, extracted twice with 50 ml of methylene chloride, washed with 20 ml of water, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure to obtain a residue. 15 ml of ethyl acetate was added to the residue, and the mixture was refluxed for 20 minutes, and cooled slowly to room temperature. An impure target compound (6.0 g) was obtained. 3.3 ml of concentrated hydrochloric acid was added to 30 ml of water for purification, and the product was completely dissolved. Stirring gradually with neutralizing aqueous solution of OdA gives a precipitate (pH 5-6), and filtration and drying gives the title compound (5,33 g, 69.6%).

용점 : 137∼139℃Melting point: 137 ~ 139 ℃

1R(KBr) : 3100, 1620cm-1 1R (KBr): 3100, 1620cm -1

1H NMR (CDC13) : δ4.40∼4.80(dd, 4H) 5.50(s. 1H) 6.70∼6.90(m, 2H) 7.35∼7.50(m, 1H) 7.85(s, 2H) 8.05(s, 2H) 1 H NMR (CDC1 3 ): δ 4.40 to 4.80 (dd, 4H) 5.50 (s. 1H) 6.70 to 6.50 (m, 2H) 7.35 to 7.50 (m, 1H) 7.85 (s, 2H) 8.05 (s, 2H)

실시예 4 : 2-(2, 4-디플루오로페닐)-1, 3-비스(1H-1, 2, 4-트리아졸-1-일)-2-프로판을(1)Example 4: 2- (2, 4-difluorophenyl) -1, 3-bis (1H-1, 2, 4-triazol-1-yl) -2-propane (1)

1-[2-(2, 4-디플루오로페닐)-2, 3-에폭시프로필]-1H-1, 2, 4-트리아졸(5.93g, 25mmol)를 디메틸포름아미드 10ml에 녹이고 90℃로 가열한 후 나트륨플루오라이드 0.18g(0.05eq)을 적가하고 디메틸포름아미드 5ml에 녹인 실릴트리아졸 4.59g, 1.3당량)을 30분간 서서히 적가하고 90℃에서 3시간동안 교반시킨다. 반응물을 실온으로 냉각시킨 후 메틸렌클로라이드 40ml와 물 30ml를 가한다. 유기층을 물 30ml씩 2회 세척하여 디메틸포름아미드를 제거하고 감압하에서 농축하면 잔사물이 수득된다. 이 잔사물에 물 10ml와 농염산 4.4ml를 가하고 실온에서 1시간동안 교반한다. 이 반응물에 4N-가성소오다 수용액으로 서서히 중화시키고 메틸렌클로라이드 50ml로 2회 추출하고 무수마그네슘설페이트로 건조시켜 감압하에서 농축하면 잔사물이 수득된다. 이 잔사물에 에틸아세테이트 10ml를 가하고 20분동안 환류시키고 실온으로 서서히 냉각시키면 화합물(4.44g)이 수득된다. 이 화합물에 물 30ml와 농염산 3.3ml를 가하고 화합물을 완전히 녹인 후 4N-가성소오다 수용액으로 서서히 중화시키면서 교반하면 침전물이 얻어지고 (pH 5∼6)여과하여 건조하면 표제화합물(5,17g, 67.5%)이 수득된다.Dissolve 1- [2- (2,4-difluorophenyl) -2,3-epoxypropyl] -1H-1,2,4-triazole (5.93 g, 25 mmol) in 10 ml of dimethylformamide and proceed to 90 ° C. After heating, 0.18 g (0.05 eq) of sodium fluoride was added dropwise, and 4.59 g (1.3 equivalents) of silyltriazole dissolved in 5 ml of dimethylformamide was slowly added dropwise for 30 minutes and stirred at 90 ° C. for 3 hours. After the reaction was cooled to room temperature, 40 ml of methylene chloride and 30 ml of water were added thereto. The organic layer was washed twice with 30 ml of water to remove dimethylformamide and concentrated under reduced pressure to give a residue. 10 ml of water and 4.4 ml of concentrated hydrochloric acid are added to the residue, followed by stirring at room temperature for 1 hour. The reaction was slowly neutralized with 4N aqueous sodium hydroxide solution, extracted twice with 50 ml of methylene chloride, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain a residue. To the residue was added 10 ml of ethyl acetate, refluxed for 20 minutes, and cooled slowly to room temperature to give a compound (4.44 g). 30 ml of water and 3.3 ml of concentrated hydrochloric acid were added to the compound, and the compound was completely dissolved. After stirring, the mixture was gradually neutralized with 4N aqueous sodium hydroxide solution and stirred to obtain a precipitate (pH 5-6). 67.5%) is obtained.

용점 : 137∼139℃Melting point: 137 ~ 139 ℃

1R(KBr) : 3100, 1620cm-1 1R (KBr): 3100, 1620cm -1

1H NMR(CDC13) : δ4.40∼4.80(dd, 4H) 5.50(s, 1H) 6.70∼6.90(m, 2H) 7.35∼7.50(m, 1H) 7.85(s, 2H) 8.05(s, 2H) 1 H NMR (CDC1 3 ): δ 4.40 to 4.80 (dd, 4H) 5.50 (s, 1H) 6.70 to 6.50 (m, 2H) 7.35 to 7.50 (m, 1H) 7.85 (s, 2H) 8.05 (s, 2H)

실시예 5 : 2-(2, 4-디플루오로페닐)-1, 3-비스(1H 1, 2, 4-트리아졸-1-일)-2-프로판을(1)Example 5: 2- (2, 4-difluorophenyl) -1, 3-bis (1H 1, 2, 4-triazol-1-yl) -2-propane (1)

1-[2-(2, 4-디플루오로페닐)-2, 3-에폭시프로필]-1H-1, 2, 4-트리아졸(5.93g, 25mmol)를 디메틸포름아미드 10ml 에 녹이고 90℃로 가열한 후 테트라부틸암모늄플루오라이드 0.25ml(1N, THF)을 적가하고 디메틸포름아미드 5ml 에 녹인 실릴트리아졸(4.59g, 1.3당량)을 30분간 서서히 적가하고 90℃에서 3시간동안 교반시킨다. 반응물을 실온으로 냉각시킨 후 메틸렌클로라이드 40ml와 물 30ml를 가한다. 유기층을 물 30ml씩 2회 세척하여 디메틸포름아미드를 제거하고 감압하에서 농축하면 잔사물이 수득된다. 이 잔사물에 물 30ml와 농염산 4.4ml를 가하고 실온에서 1시간동안 교반한다. 이 반응물을 4N- 가성소오다 수용액으로 서서히 중화기키면 침전물이 생성되고 여과하면 잔사물이 수득된다. 이 잔사물에 물 30ml와 농염산 3.3ml를 가하고 완전히 용해시키고 4N-가성소오다 수용액으로 서서히 중화하면서 교반하면 침전물이 얻어지고 (pH 5∼6)여과하여 건조하면 표제화합물이 수득된다. 이 목적화합물에 이소프로필알콜 10ml를 가하고 20분동안 환류시키고 실온으로 서서히 냉각시키면 표제화합물 (4.97g, 64.9%)이 수득된다.Dissolve 1- [2- (2,4-difluorophenyl) -2,3-epoxypropyl] -1H-1,2,4-triazole (5.93 g, 25 mmol) in 10 ml of dimethylformamide and proceed to 90 ° C. After heating, 0.25 ml (1N, THF) of tetrabutylammonium fluoride was added dropwise, and silyltriazole (4.59 g, 1.3 equivalents) dissolved in 5 ml of dimethylformamide was slowly added dropwise for 30 minutes, followed by stirring at 90 ° C for 3 hours. After the reaction was cooled to room temperature, 40 ml of methylene chloride and 30 ml of water were added thereto. The organic layer was washed twice with 30 ml of water to remove dimethylformamide and concentrated under reduced pressure to give a residue. 30 ml of water and 4.4 ml of concentrated hydrochloric acid are added to the residue, followed by stirring at room temperature for 1 hour. The reaction is slowly neutralized with 4N aqueous sodium hydroxide solution to form a precipitate, which is filtered to give a residue. To this residue was added 30 ml of water and 3.3 ml of concentrated hydrochloric acid, completely dissolved, and slowly neutralized with 4N aqueous sodium hydroxide solution. The precipitate was obtained by stirring (pH 5-6), and the title compound was obtained by filtration and drying. To this target compound was added 10 ml of isopropyl alcohol, refluxed for 20 minutes and cooled slowly to room temperature to give the title compound (4.97 g, 64.9%).

용점 : 137∼139℃Melting point: 137 ~ 139 ℃

1R(KBr) : 3100, 1620cm-1 1R (KBr): 3100, 1620cm -1

1H NMR(CDC13) : δ4.40∼4.80(dd, 4H) 5.50(s, 1H) 6.70∼6.90(m, 2H) 7.35∼7.50(m, 1H) 7.85(s, 2H) 8.05(s, 2H) 1 H NMR (CDC1 3 ): δ 4.40 to 4.80 (dd, 4H) 5.50 (s, 1H) 6.70 to 6.50 (m, 2H) 7.35 to 7.50 (m, 1H) 7.85 (s, 2H) 8.05 (s, 2H)

Claims (3)

테트라 알킬암모늄할라이드 또는 알칼리 금속 할라이드 촉매 존재하에서 하기 화학식(2)의 화합물과 실릴트리아졸(3)을 반응시켜 하기 화학식(4)의 화합물을 제조하고 이를 산조건하에서 타실릴화하여 하기 화학식(1)의 화합물을 제조하는 방법.In the presence of a tetra alkylammonium halide or an alkali metal halide catalyst, a compound of formula (2) is reacted with silyltriazole (3) to prepare a compound of formula (4), which is then tasylyzed under acidic conditions to give a compound of formula (1) To prepare a compound.
Figure kpo00005
Figure kpo00005
제1항에 있어서, 테트라알킬암모늄할라이드가 테트라부틸암모늄요오다이드에서 선택되는 것을 특징으로 하는 방법.The method of claim 1 wherein the tetraalkylammonium halide is selected from tetrabutylammonium iodide. 제 1항에 있어서, 알칼리금속할라이드가 나트륨플루오라이드, 칼륨플루오라이드, 나트륨요오다이드, 칼륨요오다이드에서 선택되는 것을 특징으로 하는 방법.The method of claim 1 wherein the alkali metal halide is selected from sodium fluoride, potassium fluoride, sodium iodide, potassium iodide.
KR1019970023862A 1997-06-10 1997-06-10 Preparation method for bis-triazole derivatives KR100204096B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970023862A KR100204096B1 (en) 1997-06-10 1997-06-10 Preparation method for bis-triazole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970023862A KR100204096B1 (en) 1997-06-10 1997-06-10 Preparation method for bis-triazole derivatives

Publications (2)

Publication Number Publication Date
KR19990000773A KR19990000773A (en) 1999-01-15
KR100204096B1 true KR100204096B1 (en) 1999-06-15

Family

ID=19509059

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970023862A KR100204096B1 (en) 1997-06-10 1997-06-10 Preparation method for bis-triazole derivatives

Country Status (1)

Country Link
KR (1) KR100204096B1 (en)

Also Published As

Publication number Publication date
KR19990000773A (en) 1999-01-15

Similar Documents

Publication Publication Date Title
US7705159B2 (en) Process for the preparation of letrozole
EP0274379B1 (en) Process for preparing pyridine-2,3-dicarboxylic acid compounds
US4182862A (en) Process for the preparation of 1,3-disubstituted-2-azoyl-2-propen-1-ones
EP3915981B1 (en) Method for preparation of efinaconazole in ionic liquid medium
KR100204096B1 (en) Preparation method for bis-triazole derivatives
KR100369274B1 (en) Improved process for producing 4-hydroxy-2-pyrrolidone
EP0370357B1 (en) Process for producing 3-iminonitriles
WO1998032744A1 (en) Process for manufacturing fluconazole
KR100283991B1 (en) Method for preparing bis-triazole derivative
JP2804559B2 (en) Method for producing 2-chloro-5-chloromethylpyridine
JP7530384B2 (en) (R)-(2-Methyloxiran-2-yl)methyl 4-bromobenzenesulfonate
KR100192150B1 (en) Preparation method of bis-triazole derivatives
KR100200246B1 (en) Preparation method of triazole derivatives
KR860001335B1 (en) Process for preparation of 3-phenyl pyroles
US7629469B2 (en) Intermediate for the preparation of paliperidone
KR102638538B1 (en) New process for preparing intermediate of urapidil
KR100335848B1 (en) Azetidinone derivatives, a process for their preparation and a method for producing 1-β-alkylazetidinone using the same
EP0611758B1 (en) Process for synthesizing 4-halo-5(hydroxymethyl) imidazole compounds and certain novel 4-halo-5(hydroxymethyl) imidazole compounds
US4720550A (en) Process for producing imidazolylthiophenaldehydes
WO2024049748A1 (en) A new and efficient process for preparing 3 -halo-4, 5-dihydro-1h-pyrazoles
KR100209246B1 (en) Manufacturing method of triazole derivatives
KR100209245B1 (en) Manufacturing method of triazole derivatives
JPH06107641A (en) Production of 1-@(3754/24)2-carboxyphenyl)indazole derivative
CN115611870A (en) Preparation method of isavuconazole intermediate V
KR100341688B1 (en) Process for the Preparation of Fluconazole

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20121210

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20131211

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20141210

Year of fee payment: 17

LAPS Lapse due to unpaid annual fee